About the job
Axsome Therapeutics is a pioneering biopharmaceutical company at the forefront of revolutionizing the treatment of central nervous system (CNS) disorders. Our commitment to medical innovation drives us to bridge critical gaps in patient care by developing unique therapeutic solutions focused on novel mechanisms of action, aimed at achieving significant improvements in patient outcomes. Our cutting-edge neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness related to narcolepsy and obstructive sleep apnea, and migraines, alongside several late-stage development programs targeting a wide spectrum of serious neurological and psychiatric illnesses affecting over 150 million individuals across the United States. Together, we strive to tackle some of the most challenging issues concerning brain health, empowering patients and their families to thrive.